in

Houston Business Journal Announces DECISIO Health as Recipient of the Innovation Awards

Last month the Houston Business Journal announced DECISIO Health as a recipient of the Innovation Awards. The award honors Houston’s most innovative companies at the fourth annual Innovation Awards. More than just a startup/tech awards program, Houston Business Journal recognizes innovation across all industries and all facets of business. The evaluation criteria ensures that all companies, regardless of industry, domain or innovation type can clearly communicate, affirm and support their nomination. DECISIO Health will be featured in a special section of the Houston Business Journal’s September 23rd weekly edition.

DECISIO recently gained a patent related to a computer program product providing a novel patient dashboard system in a hospital setting. The flagship product, InsightIQ, reduces clinical variation, improves patient outcomes while decreasing costs with digitized bundles of care that prioritizes clinicians’ attention to at-risk patients requiring early intervention. 

“We are excited and honored to receive this award. We feel this reflects the passion our company has for improving patients’ outcomes and our customers’ confidence in our products.” said Co-CEO Dr. John Holcomb.

About DECISIO®

DECISIO is a Houston-based digital health company with a customizable clinical decision support platform designed to aggregate and prioritize real-time data, from any device, and present it visually in one place. The flagship product, InsightIQ, uses continuous smart bedside monitoring which enables clinical teams to efficiently identify patients at risk and comply with established clinical guidelines. InsightIQ improves patient outcomes and throughput, optimizes workflow, increases collaboration, thus reducing length of stay and “click” fatigue. Our solutions, including actionable analytics, can be scaled across an entire health system or used in a single care area.

Phantom Neuro Announces $6M in Expanded Seed Funding Led by New Investor Time Bioventures and Risk & Return

Waqas Durrani Promoted to Senior Vice President in USAA’s Chief Legal Office